Xiaohua Xu

1.8k total citations
66 papers, 1.4k citations indexed

About

Xiaohua Xu is a scholar working on Molecular Biology, Hematology and Neurology. According to data from OpenAlex, Xiaohua Xu has authored 66 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 8 papers in Hematology and 7 papers in Neurology. Recurrent topics in Xiaohua Xu's work include Lipid Membrane Structure and Behavior (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Neurogenesis and neuroplasticity mechanisms (5 papers). Xiaohua Xu is often cited by papers focused on Lipid Membrane Structure and Behavior (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Neurogenesis and neuroplasticity mechanisms (5 papers). Xiaohua Xu collaborates with scholars based in China, United States and Hong Kong. Xiaohua Xu's co-authors include Arthur E. Warrington, Moses Rodriguez, Rongzhen Xu, Shelia D. Thomas, Xiaoxian Gan, Donald M. Miller, Paula J. Bates, Sang‐Hyun Oh, Xiaoying Zhao and Nathan J. Wittenberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Xiaohua Xu

62 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohua Xu China 19 829 157 138 111 110 66 1.4k
Ho-Jae Lee South Korea 26 996 1.2× 265 1.7× 192 1.4× 196 1.8× 90 0.8× 75 1.8k
Amir M. Hossini Germany 23 1.0k 1.3× 144 0.9× 257 1.9× 140 1.3× 59 0.5× 36 1.9k
Maria Grazia Bottone Italy 26 943 1.1× 340 2.2× 161 1.2× 133 1.2× 202 1.8× 106 1.8k
Shwu‐Fen Chang Taiwan 25 802 1.0× 80 0.5× 173 1.3× 122 1.1× 132 1.2× 65 1.7k
Xin Guo China 23 1.2k 1.5× 208 1.3× 159 1.2× 358 3.2× 124 1.1× 54 1.8k
Jaganmohan R. Jangamreddy Sweden 13 698 0.8× 189 1.2× 85 0.6× 150 1.4× 101 0.9× 20 1.4k
Csaba Vízler Hungary 25 669 0.8× 223 1.4× 435 3.2× 174 1.6× 59 0.5× 69 1.6k
José Luis Urdiales Spain 22 984 1.2× 163 1.0× 314 2.3× 116 1.0× 159 1.4× 48 1.6k
Yeung Bae Jin South Korea 23 854 1.0× 287 1.8× 210 1.5× 150 1.4× 43 0.4× 75 1.6k
Roberto Giovannoni Italy 25 1.1k 1.4× 366 2.3× 220 1.6× 204 1.8× 39 0.4× 69 2.0k

Countries citing papers authored by Xiaohua Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaohua Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohua Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohua Xu more than expected).

Fields of papers citing papers by Xiaohua Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohua Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohua Xu. The network helps show where Xiaohua Xu may publish in the future.

Co-authorship network of co-authors of Xiaohua Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohua Xu. A scholar is included among the top collaborators of Xiaohua Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohua Xu. Xiaohua Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garralda, Elena, Víctor Moreno, Alessandra Santoro, et al.. (2025). 1522MO A phase I study of INCA33890, a PD-1/TGFβR2 bispecific antibody, for advanced solid tumours. Annals of Oncology. 36. S849–S850.
2.
Kong, Xiaocen, et al.. (2025). Effect of Ebenatide on glycemic metabolism and body fat in patients with type 2 diabetes mellitus. Frontiers in Endocrinology. 16. 1622526–1622526.
3.
Xiao, Ting Ting, Xiaofeng Li, Xiaohua Xu, et al.. (2024). Biomimetic mineralization of collagen from fish scale to construct a functionally gradient lamellar bone-like structure for guided bone regeneration. International Journal of Biological Macromolecules. 281(Pt 3). 136454–136454. 5 indexed citations
5.
Hao, Yuanyuan, Xian Li, Yun Liang, et al.. (2022). Aberrantly Activated APOBEC3B Is Associated With Mutant p53-Driven Refractory/Relapsed Diffuse Large B-Cell Lymphoma. Frontiers in Immunology. 13. 888250–888250. 7 indexed citations
6.
Yuan, Xianggui, Yurong Huang, Hua‐Wei Jiang, et al.. (2022). Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma. Scientific Reports. 12(1). 21541–21541. 1 indexed citations
7.
Xu, Xiaoyuan, et al.. (2021). Downregulation of microRNA‑96‑5p protects TM3 cells against zearalenone toxicity via targeting ATG9A. Experimental and Therapeutic Medicine. 22(5). 1209–1209. 3 indexed citations
8.
Xu, Xiaohua, et al.. (2021). Molecular Mechanisms of the RECQ4 Pathogenic Mutations. Frontiers in Molecular Biosciences. 8. 791194–791194. 12 indexed citations
9.
Xu, Xiaohua, et al.. (2020). Pathogenic mutations reveal a role of RECQ4 in mitochondrial RNA:DNA hybrid formation and resolution. Scientific Reports. 10(1). 17033–17033. 6 indexed citations
10.
Gui, Wang, et al.. (2020). Coexistence of Crohn’s disease and systemic lupus erythematosus: a case report and literature review. European Journal of Gastroenterology & Hepatology. 32(9). 1256–1262. 8 indexed citations
11.
Xu, Xiaohua, Nathan J. Wittenberg, Luke R. Jordan, et al.. (2013). A patterned recombinant human IgM guides neurite outgrowth of CNS neurons. Scientific Reports. 3(1). 2267–2267. 17 indexed citations
12.
Xu, Xiaohua, Yichao Gan, Ting Chen, et al.. (2012). Tetrandrine citrate eliminates imatinib-resistant chronic myeloid leukemia cells in vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis. Journal of Zhejiang University SCIENCE B. 13(11). 867–874. 18 indexed citations
13.
Xu, Xiaohua, Jennifer L. Harder, Daniel C. Flynn, & Lorene M. Lanier. (2009). AFAP120 regulates actin organization during neuronal differentiation. Differentiation. 77(1). 38–47. 7 indexed citations
14.
Liang, Yun, et al.. (2009). Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo. Acta Pharmacologica Sinica. 30(4). 451–457. 43 indexed citations
15.
Gu, Ying, Ting Zhang, Xuzhao Zhang, et al.. (2009). Linalool preferentially induces robust apoptosis of a variety of leukemia cells via upregulating p53 and cyclin-dependent kinase inhibitors. Toxicology. 268(1-2). 19–24. 75 indexed citations
16.
Harder, Jennifer L., Xiaohua Xu, Paul C. Letourneau, & Lorene M. Lanier. (2008). The actin cross-linking protein AFAP120 regulates axon elongation in a tyrosine phosphorylation-dependent manner. Neuroscience Letters. 444(2). 132–136. 4 indexed citations
17.
Rich, Adam, et al.. (2007). Kit‐like immunoreactivity in the zebrafish gastrointestinal tract reveals putative ICC. Developmental Dynamics. 236(3). 903–911. 31 indexed citations
18.
Xu, Rongzhen, Qinghua Dong, Xiaoying Zhao, et al.. (2005). Berbamine: A novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity. Leukemia Research. 30(1). 17–23. 61 indexed citations
19.
Xu, Xiaohua, et al.. (2004). Detection and clinical significance of thrombomodulin in both plasma and tissue extracts of cancer patients. Chinese Journal of Cancer Research. 16(2). 105–108. 1 indexed citations
20.
Mi, Yingchang, Shelia D. Thomas, Xiaohua Xu, et al.. (2003). Apoptosis in Leukemia Cells Is Accompanied by Alterations in the Levels and Localization of Nucleolin. Journal of Biological Chemistry. 278(10). 8572–8579. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026